Integrated Quantitative Investments LLC
Position in RIGL — Rigel Pharmaceuticals Inc
CIK 2046834
BELLEVUE, WA
Position in RIGL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$219,970
-$128,452 QoQ
Shares Held
8,135
0.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Integrated Quantitative Investments LLC holds $8,725,728 across 13 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
90,718 | $2,492,023 | |
| 2 | RAPP |
Rapport Therapeutics, Inc.
|
30,386 | $1,266,184 | |
| 3 | PRAX |
Praxis Precision Medicines, Inc.
|
3,173 | $1,062,288 | |
| 4 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
146,065 | $911,445 | |
| 5 | PGEN |
Precigen, Inc.
|
90,655 | $516,733 | |
| 6 | CLYM |
Climb Bio, Inc.
|
31,406 | $409,534 | |
| 7 | ABUS |
Arbutus Biopharma Corp
|
79,937 | $383,697 | |
| 8 | INCY |
Incyte Corp
|
3,301 | $374,201 |
All Filings in RIGL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $219,970 | 8,135 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $348,422 | 8,135 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $300,298 | 10,600 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $199,324 | 10,642 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $192,151 | 10,681 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $180,966 | 10,759 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||